Effect of breathing techniques and oral exercises in patients with breathing difficulties during sleep.

Effect of Comprehensive Rehabilitation on Apnea Hypopnea Index in patients with Obstructive Sleep Apnea: A Randomized Controlled Trial - NIL

Status

Active, not recruiting

Phases

Phase 1Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2023/10/058486

Enrollment

118

Registered

2023-10-10

Start date

Unknown

Completion date

Unknown

Last updated

2023-10-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: J988- Other specified respiratory disorders

Interventions

Intervention1: Comprehensive Rehabilitation: Functional Nasal Breathing Rehabilitation techniques Myofunctional Therapy Diaphragmatic Breathing Exercise Frequency - 3 times/day for 5 days a week Durat

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patients diagnosed with mild and moderate OSA (with AHI =5 to = 30) 2. BMI less than 40 kg/m2

Exclusion criteria

Exclusion criteria: 1. Patients with obstructive nasal disease such as allergic rhinitis. 2. Individuals with craniofacial malformations. 3. Patients diagnosed with comorbid sleep disorders such as insomnia, restless leg syndrome. 4. Pregnant women 5. Patients with history of pharyngeal surgery. 6. Patients with history of congestive heart failure, cardiomyopathy, chronic obstructive pulmonary disease, liver cirrhosis. 7. Patients with history of neuromuscular disorders such as myasthenia gravis, motor neuron disease, demyelinating diseases. 8. Patients with history of stroke. 9. Patients with psychiatric illness such as schizophrenia, anxiety disorder, obsessive compulsive disorder, bipolar disorder, attention deficit disorder and hyperactivity disorder. 10. Consumption of alcoholic beverages regularly. 11. Periodontal disease (gingivitis) 12. Temporomandibular Joint dysfunction

Design outcomes

Primary

Measure	Time frame
1. Apnea Hypopnea Index 2. Epworth Sleepiness ScaleTimepoint: 1. At baseline (0 weeks), End of the treatment (12 weeks) 2. At baseline (0 weeks), End of the treatment (12 weeks), Follow up (24 weeks)	—

Secondary

Measure	Time frame
1. Oxygen Desaturation Index 2. Snoring Index 3. Pittsburg Sleep Quality Index 4. Manual Assessment of Respiratory Motion 5. Breath Hold Test 6. Self Evaluation of Breathing QuestionnaireTimepoint: 1. At baseline (0 weeks), End of the treatment (12 weeks) 2. At baseline (0 weeks), End of the treatment (12 weeks) 3. At baseline (0 weeks), End of the treatment (12 weeks), Follow up (24 weeks) 4. At baseline (0 weeks), End of the treatment (12 weeks), Follow up (24 weeks) 5. At baseline (0 weeks), End of the treatment (12 weeks), Follow up (24 weeks) 6. At baseline (0 weeks), End of the treatment (12 weeks), Follow up (24 weeks)	—

Measure

Time frame

1. Oxygen Desaturation Index 2. Snoring Index 3. Pittsburg Sleep Quality Index 4. Manual Assessment of Respiratory Motion 5. Breath Hold Test 6. Self Evaluation of Breathing QuestionnaireTimepoint: 1. At baseline (0 weeks), End of the treatment (12 weeks) 2. At baseline (0 weeks), End of the treatment (12 weeks) 3. At baseline (0 weeks), End of the treatment (12 weeks), Follow up (24 weeks) 4. At baseline (0 weeks), End of the treatment (12 weeks), Follow up (24 weeks) 5. At baseline (0 weeks), End of the treatment (12 weeks), Follow up (24 weeks) 6. At baseline (0 weeks), End of the treatment (12 weeks), Follow up (24 weeks)

—

Countries

India

Contacts

Public ContactDr Prem V

Manipal College of Health Professions

prem.v@manipal.edu9886647732

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 9, 2026